Form 8-K - Current report:
SEC Accession No. 0001628280-22-006314
Filing Date
2022-03-16
Accepted
2022-03-16 07:31:35
Documents
35
Period of Report
2022-03-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K avtx-20220316.htm   iXBRL 8-K 33482
2 EX-99.1 ex-991_avtxxirxdeckxfina.htm EX-99.1 24828
6 GRAPHIC ex-991_avtxxirxdeckxfina001.jpg GRAPHIC 114373
7 GRAPHIC ex-991_avtxxirxdeckxfina002.jpg GRAPHIC 230836
8 GRAPHIC ex-991_avtxxirxdeckxfina003.jpg GRAPHIC 135655
9 GRAPHIC ex-991_avtxxirxdeckxfina004.jpg GRAPHIC 100830
10 GRAPHIC ex-991_avtxxirxdeckxfina005.jpg GRAPHIC 93157
11 GRAPHIC ex-991_avtxxirxdeckxfina006.jpg GRAPHIC 124324
12 GRAPHIC ex-991_avtxxirxdeckxfina007.jpg GRAPHIC 55118
13 GRAPHIC ex-991_avtxxirxdeckxfina008.jpg GRAPHIC 82837
14 GRAPHIC ex-991_avtxxirxdeckxfina009.jpg GRAPHIC 124902
15 GRAPHIC ex-991_avtxxirxdeckxfina010.jpg GRAPHIC 97074
16 GRAPHIC ex-991_avtxxirxdeckxfina011.jpg GRAPHIC 93262
17 GRAPHIC ex-991_avtxxirxdeckxfina012.jpg GRAPHIC 64774
18 GRAPHIC ex-991_avtxxirxdeckxfina013.jpg GRAPHIC 140028
19 GRAPHIC ex-991_avtxxirxdeckxfina014.jpg GRAPHIC 108464
20 GRAPHIC ex-991_avtxxirxdeckxfina015.jpg GRAPHIC 125338
21 GRAPHIC ex-991_avtxxirxdeckxfina016.jpg GRAPHIC 56533
22 GRAPHIC ex-991_avtxxirxdeckxfina017.jpg GRAPHIC 149088
23 GRAPHIC ex-991_avtxxirxdeckxfina018.jpg GRAPHIC 120313
24 GRAPHIC ex-991_avtxxirxdeckxfina019.jpg GRAPHIC 125023
25 GRAPHIC ex-991_avtxxirxdeckxfina020.jpg GRAPHIC 51819
26 GRAPHIC ex-991_avtxxirxdeckxfina021.jpg GRAPHIC 65896
27 GRAPHIC ex-991_avtxxirxdeckxfina022.jpg GRAPHIC 90418
  Complete submission text file 0001628280-22-006314.txt   3441193

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avtx-20220316.xsd EX-101.SCH 1979
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avtx-20220316_lab.xml EX-101.LAB 24319
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avtx-20220316_pre.xml EX-101.PRE 12712
29 EXTRACTED XBRL INSTANCE DOCUMENT avtx-20220316_htm.xml XML 10017
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37590 | Film No.: 22743296
SIC: 2834 Pharmaceutical Preparations